Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Seungyeon, Jung"'
Autor:
Xue Bai, MD, Aleigha R. Lawless, BS, Juliane A. Czapla, MS, Stefanie C. Gerstberger, MD, PhD, Benjamin C. Park, MD, Seungyeon Jung, BA, Rebecca Johnson, MN, Naoya Yamazaki, MD, PhD, Dai Ogata, MD, PhD, Yoshiyasu Umeda, MD, Caili Li, MB, Jun Guo, MD, PhD, Keith T. Flaherty, MD, Yasuhiro Nakamura, MD, PhD, Kenjiro Namikawa, MD, PhD, Georgina V. Long, MBBS, PhD, Alexander M. Menzies, MBBS, PhD, Douglas B. Johnson, MD, Ryan J. Sullivan, MD, Genevieve M. Boland, MD, PhD, Lu Si, MD
Publikováno v:
JAAD International, Vol 15, Iss , Pp 105-114 (2024)
Background: Anti-Program-Death-1 (PD-1) is a standard adjuvant therapy for patients with resected melanoma. We hypothesized that there are discrepancies in survival, recurrence pattern and toxicity to adjuvant PD-1 between different ethnicities and m
Externí odkaz:
https://doaj.org/article/e27b5891bd9c4bf4a452fb755d884e7b
Autor:
Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D. d’Arienzo, Florentia Mina, Juliane A. Czapla, Aleigha R. Lawless, Eleonora Bongiovanni, Umberto Santaniello, Helena Zappi, Dominika Dulak, Andrew Williamson, Rebecca Lee, Avinash Gupta, Caili Li, Lu Si, Martina Ubaldi, Naoya Yamazaki, Dai Ogata, Rebecca Johnson, Benjamin C. Park, Seungyeon Jung, Gabriele Madonna, Juliane Hochherz, Yoshiyasu Umeda, Yasuhiro Nakamura, Christoffer Gebhardt, Lucia Festino, Mariaelena Capone, Paolo Antonio Ascierto, Douglas B. Johnson, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies, Kenjiro Namikawa, Mario Mandala, Jun Guo, Paul Lorigan, Yana G. Najjar, Andrew Haydon, Pietro Quaglino, Genevieve M. Boland, Ryan J. Sullivan, Andrew J.S. Furness, Ruth Plummer, Keith T. Flaherty
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102564- (2024)
Externí odkaz:
https://doaj.org/article/377d8aad4882472db54c2cd4b6fbb9b1
Autor:
Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D. d’Arienzo, Florentia Mina, Juliane A. Czapla, Aleigha R. Lawless, Eleonora Bongiovanni, Umberto Santaniello, Helena Zappi, Dominika Dulak, Andrew Williamson, Rebecca Lee, Avinash Gupta, Caili Li, Lu Si, Martina Ubaldi, Naoya Yamazaki, Dai Ogata, Rebecca Johnson, Benjamin C. Park, Seungyeon Jung, Gabriele Madonna, Juliane Hochherz, Yoshiyasu Umeda, Yasuhiro Nakamura, Christoffer Gebhardt, Lucia Festino, Mariaelena Capone, Paolo Antonio Ascierto, Douglas B. Johnson, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies, Kenjiro Namikawa, Mario Mandala, Jun Guo, Paul Lorigan, Yana G. Najjar, Andrew Haydon, Pietro Quaglino, Genevieve M. Boland, Ryan J. Sullivan, Andrew J.S. Furness, Ruth Plummer, Keith T. Flaherty
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102290- (2023)
Summary: Background: Both dabrafenib/trametinib (D/T) and anti-PD-1 monotherapy (PD-1) are approved adjuvant therapies for patients with stage III BRAF V600-mutant melanoma. However, there is still a lack of head-to-head comparative data. We aimed to
Externí odkaz:
https://doaj.org/article/43eb9c43eb9a4af8ab0b21da71b61e89
Autor:
Stephen R. Norris, Seungyeon Jung, Prashant Singh, Claire E. Strothman, Amanda L. Erwin, Melanie D. Ohi, Marija Zanic, Ryoma Ohi
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
Microtubules (MT) form higher-order structures such as asters, but the molecular pathway underlying aster formation remains unclear. Here authors demonstrate that the kinesin-14, HSET, clusters with soluble (nonMT) tubulin via its N-terminal tail dom
Externí odkaz:
https://doaj.org/article/417c0f27487b4b12b0815280d321f6b5
Publikováno v:
American Journal of Clinical Dermatology. 23:707-717
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a881622b85e8593302517444d450e95
https://doi.org/10.1007/s40257-022-00706-y
https://doi.org/10.1007/s40257-022-00706-y
Publikováno v:
The Oncologist. 27:e967-e969
Immune checkpoint inhibitor (ICI)-induced hypophysitis is an immune-mediated pituitary inflammation that tends to cause long-term pituitary deficiency. Management of ICI-induced hypophysitis includes corticosteroids for acute inflammation and long-te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9188520c39f2852e4301bf88bb54ccd2
https://doi.org/10.1093/oncolo/oyac220
https://doi.org/10.1093/oncolo/oyac220
Autor:
Seungyeon, Jung, Douglas B, Johnson
Publikováno v:
The Oncologist. 27:703-710
Acral and mucosal melanomas (MM) are rare subtypes of melanoma that are biologically and clinically distinct from cutaneous melanoma. Despite the progress in the treatment of cutaneous melanomas with the development of targeted and immune therapies,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::416b9bd39f72dc97ffccafe969ed97a9
https://doi.org/10.1093/oncolo/oyac091
https://doi.org/10.1093/oncolo/oyac091
Autor:
Seungyeon Jung, Emma Armstrong, Alexander Z. Wei, Fei Ye, Aaron Lee, Matteo S. Carlino, Ryan J. Sullivan, Richard D. Carvajal, Alexander N. Shoushtari, Douglas B. Johnson
Publikováno v:
British journal of cancer. 127(9)
Imatinib is an active agent for some patients with melanoma harbouring c-KIT alterations. However, the genetic and clinical features that correlate with imatinib sensitivity are not well-defined.We retrospectively evaluated 38 KIT-altered melanoma pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaed81fc8ed1d5a14fd784127a09c67d
https://pubmed.ncbi.nlm.nih.gov/35999272
https://pubmed.ncbi.nlm.nih.gov/35999272
The Opinion of Experts and Stakeholder on Introduction of Orphan or Anticancer Drugs Funding Program
Publikováno v:
Korean Journal of Clinical Pharmacy. 30:177-184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c6a72841ed23e86cca974c828f3caf0
https://doi.org/10.24304/kjcp.2020.30.3.177
https://doi.org/10.24304/kjcp.2020.30.3.177
Publikováno v:
Yakhak Hoeji. 61:100-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bed808b092a03ace4f05e8685a00aba
https://doi.org/10.17480/psk.2017.61.2.100
https://doi.org/10.17480/psk.2017.61.2.100